Columbia Biosciences

Columbia Biosciences is a biotechnology startup with a focus on developing and manufacturing fluorescent proteins, antibody conjugates, and novel protein purification ligands. With a founding year of 2007, the company also offers custom services such as antibody labeling, protein purification, and discovery services for pre-clinical drug development in oncology and immunology. A notable aspect of their expertise is the integration of microalgae cultures with the isolation and purification of algal fluorophores, as well as the conjugation of these and other fluorophores to antibodies. Additionally, their fluorophores are utilized in a wide range of life science products and diagnostic tools, distributed globally. As of now, there is no publicly available information regarding the company’s headquarters, last investment, or the investors involved.